Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000356444

Medchemexpress LLC Au-15330 | 2380274-50-8 | 99.9% | C39H49N9O5S | 50 MG
SDP

Supplier:  Medchemexpress LLC HY14538850MG

Encompass_Preferred

AU-15330 is a proteolysis-targeting chimera (PROTAC) degrader of the SWI/SNF ATPase subunits, SMARCA2 and SMARCA4. It potently inhibits tumor growth in xenograft models of prostate cancer and works synergistically with the AR antagonist enzalutamide. It also induces disease remission in castration-resistant prostate cancer (CRPC) models without causing toxicity.

  • Effectively inhibits tumor growth in xenograft models
  • Works synergistically with enzalutamide
  • Induces disease remission in CRPC models
  • Does not cause toxicity

Catalog No. 50-003-56444


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.